Skip to main content

RXQ Compounding LLC

No ongoing recalls currently shown

Based on the official records currently available to Public Health Trace, no recalls naming RXQ Compounding LLC are currently shown as ongoing. The 88 records below are historical recall records.

Public Health Trace has 88 recalls naming RXQ Compounding LLC as the recalling firm, republished from official FDA and USDA sources.

Recall history - 88 terminated records

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20171
20181
201986
Download CSV

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0917-01

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-55

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SOL SYR (C-IV), 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-86

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MIC (METHIONINE/INOSITOL/CHOLINE CHLORIDE) 25/50/50 MG/ML INJ, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0100-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

METHYLCOBALAMIN 1 MG/ML (MDV) INJECTABLE SOLUTION, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0915-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MAGNESIUM 200 MG/ML/ CALCIUM GLUC 6MG/ML/ ZINC 1MG/ML, 5ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0176-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

LIDOCAINE HCL 1% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0174-20

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

KETAMINE 50 MG/ML (NPV) INJECTION SOLUTION (C-III), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0173-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

Inositol/Choline B12:B6, 50/50/1/0.175 MG/ML INJ SOLN(Sulfa Free Lipostat), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0999-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0971-81

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

FOLIC ACID 5MG/ML INJECTION SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0924-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0947-01

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name RXQ Compounding LLC as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.